Disc Medicine, Inc

C4 Therapeutics, Inc. is a biotechnology company based in Watertown, MA, specializing in targeted protein degradation. Their innovative approach, known as Targeted Protein Degradation (TPD), aims to develop a new generation of medicines for treating various diseases. Through their TORPEDO platform and focus on target selection, C4 Therapeutics is dedicated to transforming lives by degrading disease-causing proteins. With a strong leadership team, board of directors, and scientific advisory board, C4 Therapeutics is committed to advancing their pipeline of therapies, including CFT7455, CFT1946, and CFT8919. They also collaborate with industry partners such as Roche, Biogen, Betta Merck, and others to further their research and development efforts. At C4 Therapeutics, their values, people, and dedication to scientific progress drive their mission to revolutionize the treatment of diseases through targeted protein degradation.Generated from the website

Exo Therapeutics, Inc., located in Cambridge, MA, is pioneering a new approach in medicine by unlocking challenging drug targets through its innovative Exosites platform. This comprehensive system is designed to modulate enzyme activity with precision and potency, primarily focusing on applications in oncology and inflammation. With a commitment to charting new territory in drug development, Exo Therapeutics is actively advancing its pipeline to create breakthrough medicines. Recent presentations at prominent conferences highlight the company's progress, including data on novel exosite inhibitors that disrupt pathological pathways in disease mechanisms. Generated from the website

Akashi Therapeutics, based in Cambridge, is a global biopharmaceutical company with a focus on developing innovative therapies for individuals affected by rare disorders. The company's mission is to create life-changing treatments that address the unmet medical needs of those living with rare diseases, aiming to improve the quality of life for patients worldwide. Generated from their website's infomation